Effects of Whole Body Vibration in Parkinson's Disease Symptoms

NCT ID: NCT05621031

Last Updated: 2022-11-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

46 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-01

Study Completion Date

2023-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to know the effects of an intervention in Parkinson's disease symptoms. The main question it aims to answer are:

* Is whole body vibration able to reduce rigidity in Parkinson's participants?
* Can whole body vibration modify gait abilities and other Parkinson's symptoms? Participants (subjects with Parkinson's disease) will do habitual therapy treatment. Experimental group will also carry out whole body vibration sessions and control group will do placebo whole body vibration sessions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PDExperimental

This group will receive usual care (physical therapy) and whole body vibration sessions.

Group Type EXPERIMENTAL

Whole body Vibration

Intervention Type DEVICE

Whole body vibration will be administered with a vibration platform (Power Plate Move). Subjects will do several exercises (squats and steps) whilst on the platform, set at these parameters: frequency 30 Hz; amplitude: 2 mm; 1 min activation; 1 min rest, 5 activations. 15 sessions will be carried out (2/week).

Habitual Therapy

Intervention Type OTHER

Physical therapy will be administered to all study subjects. Experimental group will perform their session the same day that the experimental intervention.

PDControl

This group will receive usual care (physical therapy) and placebo whole body vibration session.

Group Type ACTIVE_COMPARATOR

Habitual Therapy

Intervention Type OTHER

Physical therapy will be administered to all study subjects. Experimental group will perform their session the same day that the experimental intervention.

Placebo whole body vibration

Intervention Type DEVICE

Placebo whole body vibration will be administered with a vibration platform (Power Plate Move). Subjects will do several exercises (squats and steps) whilst on the platform. The platform will only be working for 3 seconds (parameters: frequency 30 Hz; amplitude: 2 mm) and after 3 seconds, the vibration will stop. Same as experimental group, there will be 1 min placebo activation; 1 min rest, 5 activations. 15 sessions will be carried out (2/week).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Whole body Vibration

Whole body vibration will be administered with a vibration platform (Power Plate Move). Subjects will do several exercises (squats and steps) whilst on the platform, set at these parameters: frequency 30 Hz; amplitude: 2 mm; 1 min activation; 1 min rest, 5 activations. 15 sessions will be carried out (2/week).

Intervention Type DEVICE

Habitual Therapy

Physical therapy will be administered to all study subjects. Experimental group will perform their session the same day that the experimental intervention.

Intervention Type OTHER

Placebo whole body vibration

Placebo whole body vibration will be administered with a vibration platform (Power Plate Move). Subjects will do several exercises (squats and steps) whilst on the platform. The platform will only be working for 3 seconds (parameters: frequency 30 Hz; amplitude: 2 mm) and after 3 seconds, the vibration will stop. Same as experimental group, there will be 1 min placebo activation; 1 min rest, 5 activations. 15 sessions will be carried out (2/week).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of Parkinson Disease, in phase I and II according to Hoehn \& Yahr phases.
* Able to maintain independently standing position.
* Able to understand instructions and score \>24 in Minimental Test.

Exclusion Criteria

* Changes in pharmacological treatment for PD symptoms during the study.
* Recent injuries in the last 12 weeks in lower limbs or trunk.
* Other neurological conditions not related to Parkinsonism.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Asociación de Enfermos de Parkinson de Sevilla

UNKNOWN

Sponsor Role collaborator

University of Seville

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Paula González García

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Asociación de Enfermos de Parkinson de Sevilla

Seville, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Paula González García

Role: CONTACT

954486516

Alfonso Garrido Bueno

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Oscar García Sánchez

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

USFISIOTERAPIAPGG01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Manual Therapy in Parkinson's Disease
NCT06853262 RECRUITING NA
Chinese Exercise Modalities in Parkinson's Disease
NCT00029809 COMPLETED PHASE1/PHASE2
Photobiomodulation and Parkinson
NCT03811613 COMPLETED NA